Analytical Data
-
Gene name
GRA2
- Application
-
Alternative Names
28 kDa antigen GP28.5
-
Species
Toxoplasma gondii
-
Source
E. coli
-
Tag
N- His & C- Myc
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P13404
-
Expression Region
24-185aa
-
Molecular Weight
25.0 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
GRA2, or Glycosylated Protein Related to Adhesion 2, is a vital protein found in various organisms, particularly in the context of pathogens and host interactions. Its study is primarily driven by its significant role in cellular adhesion, immune evasion, and pathogenicity. Research surrounding GRA2 is pivotal for understanding its molecular mechanisms, structure-function relationships, and potential impacts on host immune responses. In particular, GRA2 is known to be involved in the life cycle of Toxoplasma gondii, a crucial protozoan parasite that poses serious health risks to immunocompromised individuals and pregnant women. As GRA2 has been implicated in the modulation of host cell processes, its investigation is essential for developing novel therapeutic approaches aimed at mitigating the effects of T. gondii infection. Additionally, GRA2’s properties as a recombinant protein have garnered interest in vaccine research, where it could potentially serve as an antigen for eliciting robust immune responses. The exploration of GRA2 not only enhances our understanding of its biological functions but also opens pathways for innovative strategies in infectious disease control and management, making it a prominent focus within molecular biology and infectious disease research.
